| Serial Number | 90702295 |
| Word Mark | ONKAPSITI |
| Filing Date | Tuesday, May 11, 2021 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Thursday, March 14, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 23, 2022 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; monoclonal antibodies for therapeutic use for treating viral infections, inflammatory diseases, cardiovascular diseases, auto-immune diseases, blood diseases, and cancers |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 10, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MyoKardia, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005 |
| Party Name | MyoKardia, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Brisbane, CA 94005 |
| Event Date | Event Description |
| Friday, March 15, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 14, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, March 14, 2024 | SOU EXTENSION 3 FILED |
| Thursday, March 14, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 5, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 3, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, October 3, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, October 3, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, March 31, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 29, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, March 29, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, March 29, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 18, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 23, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 23, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 3, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 20, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 20, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, July 20, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 20, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 20, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, July 18, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 18, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 18, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 21, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, January 21, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 18, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, August 10, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 14, 2021 | NEW APPLICATION ENTERED |